男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

US EUROPE AFRICA ASIA 中文
Business / Economy

Getting medicine right for long-term growth

By Wang Wen (China Daily) Updated: 2015-02-10 07:52

Getting medicine right for long-term growth

Man buys medicine with the help of a pharmacy sales person in Chongqing municipality, Southwest China, July 21, 2014. [Photo/IC]

Export tax rebates will sharpen competitive advantage of health product companies in overseas markets.

The recent export tax rebate adjustments announced by the government will buoy the fortunes of Chinese medical product exporters and sharpen their competitive edge, industry experts said on Monday.

The Ministry of Finance last year announced adjustments in the export rebate rates for some goods, including 67 medicines and health products. Tax rebates for 55 Western medicines, four traditional Chinese medicines and eight medical devices have been revised upwards to between 2 and 13 percent, depending on the type of product.

About 6,100 companies from China are set to benefit from the new regulations, with the total value of their exports and imports being about $9.426 billion during the first 11 months of 2014, according to statistics provided by the China Chamber of Commerce for Import and Export of Medicines and Health Products.

Meng Dongping, vice-chairwoman of the chamber, said the tax rebates have come at an opportune time for the medical products industry, as it has been seeing slower growth rates in the past years. Medical product exports fell from a relatively high growth rate of 20 percent in 2012 to about 7 percent last year.

Breaking down the numbers further, Deng said the expected total volume of China's medicine exports and imports for 2014 would be about $100 billion and that there has been a slowdown in exports. The chamber estimates that exports will remain relatively subdued this year, while the global market growth rate would be around 4 to 7 percent.

According to Meng, the rapidly shrinking global market, rising costs and currency appreciation pressures are hurting exports.

In addition, domestic factors like higher human resource costs, raw materials, energy and environmental protection costs are fast eroding the price advantage of Chinese companies.

"The higher export rebates will help companies recoup some of the additional costs and also enhance the competitive advantage to some extent." The measures are especially beneficial for the biomedicine industry, she said.

"The adjustments mainly focus on the products with high added value and high technology, which means the government will encourage enterprises to develop such products," Meng said.

Previous Page 1 2 Next Page

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 宜兴市| 乾安县| 麻阳| 夹江县| 平乐县| 三江| 罗甸县| 贡山| 襄汾县| 勃利县| 河曲县| 龙井市| 当阳市| 固始县| 沂源县| 五莲县| 郑州市| 长葛市| 新邵县| 虞城县| 绿春县| 白玉县| 平潭县| 宁安市| 阿尔山市| 尚志市| 江孜县| 三亚市| 茌平县| 沧州市| 平山县| 安塞县| 九寨沟县| 闸北区| 普安县| 巴东县| 交口县| 南漳县| 定结县| 呼和浩特市| 焉耆|